You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Hepatocellular Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 14, 2023

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
  • (no location specified)
Jun 12, 2023

Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE（transcatheter arterial chemoembolization）
  • +2 more
  • (no location specified)
Jun 5, 2023

Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 14, 2023

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 26, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Unresectable, Non-metastatic Hepatocellular Carcinoma Trial in China (biological, drug, procedure)

Recruiting
  • Unresectable, Non-metastatic Hepatocellular Carcinoma
  • AK104
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Aug 11, 2022

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma Trial in Shanghai (Multifocal Stereotactic Radiotherapy, Atezolizumab Injection [Tecentriq],

Recruiting
  • Hepatocellular Carcinoma
  • Multifocal Stereotactic Radiotherapy
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 27, 2022

Combinational Immunotherapy, Hepatocellular Carcinoma Non-Resectable, Hyperbaric Oxygen Therapy Trial in Wuhan (hyperbaric

Recruiting
  • Combinational Immunotherapy
  • +2 more
  • hyperbaric oxygen therapy plus Camrelizumab
  • Wuhan, Hubei, China
    Hepatic Surgery Center, Tongji Hospital, Huazhong University of
Jan 23, 2022

Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +9 more
Jan 27, 2023

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • Eye90 Microspheres
  • Grafton, New Zealand
    Auckland District Health Board
Jan 30, 2023

Metastatic Hepatocellular Carcinoma, HCC, Combinations of Drugs; Dependence Trial in Tainan, Taipei (GT90001 and Nivolumab)

Active, not recruiting
  • Metastatic Hepatocellular Carcinoma
  • +2 more
  • GT90001 and Nivolumab
  • Tainan, Taiwan
  • +2 more
Jul 8, 2021

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Not yet recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Miami, Florida
  • +4 more
Aug 23, 2022

Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

Recruiting
  • Metastatic Esophageal
  • +7 more
  • LVGN3616 + LVGN6051 + Nab-Paclitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial in China (Lenvatinib,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Hefei, Anhui, China
  • +9 more
Oct 21, 2021